Menu
Model Image 15

Bring back your natural beauty

Hear more from dr Francisco
Model is not an actual patient.

The signs of facial ageing don’t necessarily mean you’re getting old.
They usually begin to appear in your twenties when your levels
of collagen and elastin (the proteins that give the skin its structure)
start to fall.

How ageing begins to show

The signs of facial ageing don’t necessarily mean you’re getting old. They usually begin to appear in your twenties when your levels of collagen and elastin (the proteins that give the skin its structure) start to fall.

The Results
Model is not an actual patient.
Model Image 22

ELLANSÉ does so much more than traditional fillers






2-in-1 Action

ELLANSÉ’s 2-in-1 action begins by correcting wrinkles and folds, then goes on to stimulate the body’s natural collagen production – resolving the underlying causes of facial ageing.






2 In 1

Immediate rejuvenation

Immediate rejuvenation

Immediate rejuvenation

ELLANSÉ effectively fills wrinkles and folds, while also redefining facial shape and contours. With its long-term collagen stimulation action, it works to reverse the signs of aging, resulting in a rejuvenated face and a noticeable enhancement in skin quality, including increased density, firmness, elasticity, tonicity, and improved texture.

Which areas can ELLANSÉ treat?

${ item.title }

${ item.title }

${ item.text }> ${ item.cta.name }
 Model is not an actual patient.
See the longevity of EllansÉ

Ask us a question

ELLANSÉ works deep under the skin

ELLANSÉ works deep under the skin

ELLANSÉ’s 2-in-1 action begins by correcting wrinkles and folds, then goes on to stimulate the body’s natural collagen production –resolving the underlying causes of facial ageing. By rebuilding and rejuvenating, layer by layer, ELLANSÉ creates a firm foundation for lasting results.
Contact us
Rivers of ink have flowed about facial ageing - almost as much as has been written about love… And all the many studies carried out reach a similar conclusion: changes to the face and its volumes affect deep fat. - Dr Francisco De Melo

Continue your education

Model Image 16

View real patient results

The power is in the results, see them for yourself - here.
Model Image 25

Ready to talk to a physician?

Use our physician finders or speak to us about finding a ELLANSÉ physician near you.
Model Image 22

Learn more with our F&Q

Find answers to yours questions, if you still need more information contact us.
Learn more about from experts

INDICATION:

The EU approved intended use is: Ellansé (a Poly-ɛ-caprolactone-based dermal filler) is an injectable implant, indicated for subdermal implantation in the face for the lasting correction of wrinkles and facial aging signs or conditions.

INDICATION:

The EU approved intended use is: Ellansé (a Poly-ɛ-caprolactone-based dermal filler) is an injectable implant, indicated for subdermal implantation in the face for the lasting correction of wrinkles and facial aging signs or conditions.

Important Safety Considerations:

Like all procedures of this type there is a possibility of adverse events, although not everybody experiences them. These adverse events include but are not limited to infection, minimal acute inflammatory tissue reaction (redness, swelling, rash, oedema, erythema, lumps/nodules etc.), pain (which may be temporary or persistent in nature), transient haematoma or bruising.

Other potential adverse events include

- Injection related reactions, include itching, discoloration or tenderness may occur at the site of the injection. These usually resolve spontaneously within several days after the injection.

- As with any implant material possible adverse reactions that may occur include, but are not limited to the following: hypersensitivity, allergic reactions, inflammation, infection, fistula formation, haematoma, seroma, extrusion, induration formation, inadequate healing, skin discoloration, oedema, contusions/bruises, ecchymosis, inadequate or excessive augmentation, loss of correction, interference with local circulation if injected into a blood vessel resulting in vessel laceration, occlusion, embolism, infarction, and abscess at implant site which may result in induration and/or scar formation.

- Rare but serious adverse events associated with the intravascular injection of soft tissue fillers in the face have been reported and include temporary or permanent vision impairment, blindness, cerebral ischemia or cerebral hemorrhage, leading to stroke, skin necrosis, damage to underlying facial structures, nausea and vomiting, lack of ocular movement, significant skin changes, ptosis, exotropia and neurological complications.

- Adverse events, other than mentioned above, could occur as can be with any medical intervention.

All (potential) adverse side effects and incidents should be reported immediately to the Sinclair Corporate Safety Group: quality@sinclair.com

For a full list of contraindications, warnings, and precautions for this product please visit http://www.sinclairpharma.com/eifu/ for a copy of the Product Instructions for Use.